Entity family

Browse institutions

Universities, hospitals, research centres, networks, and public bodies. Examples include universities, NHS trusts, research networks.

11,350articles mentioning institutions

22,378institution mentions

9,137distinct institutions extracted

0%of mentions human-reviewed

Filter articles

JournalContent resourceEvidence policyAutomated confidence floorArticles per pageReset filters

“Reviewed + threshold” includes every confirmed correction plus unreviewed proposals at or above the selected model score.

All extracted institutions

Showing 8,161–8,220 of 9,137, ordered by supporting articles. Choose a institution to see its evidence.

University Hospital of Padua1 University Hospital of Parma1 University Hospital of Siena1 University Hospital of Southampton1 University Hospital of Southern Denmark, Aabenraa1 University Hospital of Tuebingen1 University Hospital of Wales1 University Hospital of Zurich1 University Hospital of the Canary Islands1 University Hospital of the Federal University of Juiz de Fora1 University Hospitals Birmingham NHS Foundation Trust1 University Hospitals Bristol and Weston1 University Hospitals Cleveland Medical Center Institutional Review Board1 University Hospitals Dorset NHS Foundation Trust1 University Hospitals Leuven1 University Hospitals Leuven and Antwerp1 University Hospitals Plymouth NHS Trust1 University Hospitals of Antwerp and Leuven1 University Hospitals of Leicester NHS Trust1 University Hospitals of Leuven and Antwerp1 University Hospitals of Morecambe Bay NHS Foundation Trust1 University Institute for Research in Primary Care1 University Maternity Hospital Limerick1 University Medical Center Mainz1 University Medical Center Utrecht1 University Medical Centre Greifswald1 University Medical Centre Hamburg-Eppendorf1 University Medicine Duisburg/Essen1 University SEM Committees1 University Sud Mediterranean 31 University Teaching Hospital of Kigali1 University hospital Erlangen1 University of Alberta1 University of Alberta Health Research Ethics Board-Health Panel1 University of Alcalá1 University of Antwerp1 University of Athens Medical School1 University of Barcelona1 University of Bari1 University of Basel1 University of Bedfordshire Institute for Health Research Ethics Committee1 University of Belgrade School of Dental Medicine EC1 University of Benin Teaching Hospital1 University of Birmingham Edgbaston Campus1 University of Bologna1 University of Bremen1 University of British Columbia Clinical Research Ethics Board1 University of Buea1 University of Calgary Conjoint Faculties Research Ethics Board1 University of California Cancer Centers1 University of California Cancer Research Coordinating Committee1 University of California Davis1 University of California Health system1 University of California Los Angeles Institutional Review Board1 University of California San Francisco Institutional Review Board1 University of California and Los Angeles1 University of California at Los Angeles1 University of California in San Francisco1 University of California, Irvine EyeMobile Pediatric Clinic1 University of California, San Francisco Institutional Review Board1

View all 9,137 institutions on one page

Articles mentioning institutions

11,350 articles · page 170 of 946

776 Melanoma tumor cells and immunotherapy cooperatively reprogram bone marrow niches to induce early hematopoietic dysfunction and therapy-related myeloid neoplasms

jitc · abstract · 2025-11-04 · 3 matching annotations

81.4%

Embase PubMed Scopus Melanoma immune checkpoint inhibitors immune checkpoint inhibitor therapy myelodysplastic syndromes therapy-related myeloid neoplasms

…nsive literature review was conducted using PubMed, Scopus, and Embase. Studies included mechanistic models, clinical reports, and coh…

777 Natural killer cells are prognostic for head and neck squamous cell carcinoma patients treated with radiation therapy, which induces cancer cell immunogenicity in preclinical models

jitc · abstract · 2025-11-04 · 3 matching annotations

80.3%

TCGA The Cancer Genome Atlas advanced head and neck squamous cell carcinoma (HNSCC)Radiation therapy ICIs

…ic healthy mouse splenocytes followed by flow cytometry.Results TCGA analysis revealed that pre-treatment expression of a signature …

810 Chemerin-CMKLR1 axis modulates NK cell functional responses in prostate cancer

jitc · abstract · 2025-11-04 · 3 matching annotations

89.2%

Washington University School of Medicine Alvin J. Siteman Cancer Center Siteman Cancer Center rhChemerin Chemerin prostate cancer PCa α-NETA rhChemerin-treated

…s for our study. We thank the Alvin J. Siteman Cancer Center at Washington University School of Medicine, Barnes-Jewish Hospital in St. Louis, MO., for the use of the I…

852 AZD6750: design and efficacy of a CD8-guided IL-2 that enhances CD8+ T cell function

jitc · abstract · 2025-11-04 · 3 matching annotations

83.9%

NSG mice East of England - Cambridge East Research Ethics Committee UKCCR Aldesleukin AZD6750 IL-2

…ZD6750, and the activity evaluated by IFN-γ secretion. In vivo, NSG mice were implanted subcutaneously with pp65 antigen-expressing tumo…

858 Tumour-localising IL-15 superagonist for intravenous delivery enhances survival and reduces toxicity in solid tumour models

jitc · abstract · 2025-11-04 · 3 matching annotations

93.9%

Imperial College London Cancer Research UK’s Convergence Science Centre IL-15SA pancreatic adenocarcinoma CT26 PBS CT26 tumours KPC

…-approved project license and overseen by ethical committees of Imperial College London.Abstract 858 Figure 1CBD IL-15SA improves survival in CT26 and …

861 Sequential administration of WTX-124 and mWTX-330, IL-2 and IL-12 INDUKINE™ molecules, enhanced antitumor activity in mice bearing poorly immunogenic EMT6 tumors without systemic toxicity

jitc · abstract · 2025-11-04 · 3 matching annotations

87.5%

Charles River Laboratories U.S. Department of Agriculture NIH WTX-330 WTX-124 mWTX-330

… standards of the U.S. Department of Agriculture and the NIH at Charles River Laboratories with the approval of an Institutional Animal Care and Use Commi…

862 Pharmacokinetic insight into the IL-2 INDUKINE prodrug WTX-124: Real-time assessment of tumor-specific activation and immune modulation

jitc · abstract · 2025-11-04 · 3 matching annotations

84.0%

Charles River Laboratories Den Bosch B.V.Charles River Laboratories U.S Department of Health and Human Services WTX-124 INDUKINE Public Health Service

…ory Animal Welfare (OLAW). All animal studies were conducted at Charles River Laboratories Den Bosch B.V. (location Groningen, the Netherlands) with approval of the Char…

890 Intravesical recombinant MVA therapy induces local and systemic antitumor immunity and memory in an orthotopic murine bladder cancer model

jitc · abstract · 2025-11-04 · 3 matching annotations

97.7%

Memorial Sloan Kettering Cancer Center Rockefeller University MQ833 Center for Experimental Therapeutics Grant MQ710 Non-muscle-invasive bladder cancer (NMIBC)NMIBC

…10 is currently in a Phase I clinical trial for solid tumors at Memorial Sloan Kettering Cancer Center. Here, we assessed intravesical delivery of second-generation r…

895 The lack of abscopal effects with oncolytic virus immunotherapy is due to a dominant anti-viral – rather than anti-cancer – T cell response

jitc · abstract · 2025-11-04 · 3 matching annotations

87.2%

Massachusetts General Hospital MGH MGH Pathology Flow Core melanoma Talimogene laherparepvec talimogene laherparapvec pembrolizumab

…25;32(1):482–494.Ethics Approval This study was approved by the Massachusetts General Hospital (MGH) Institutional Animal Care and Use Committee; protocol num…

896 Oncolytic vaccinia virus-mediated immunotherapy increases survival and reduces tumour growth by turning immunologically ‘cold’ oestrogen receptor-positive breast tumours ‘hot’

jitc · abstract · 2025-11-04 · 3 matching annotations

87.8%

QMUL ICR Flow Cytometry Facility Breast Cancer Now Histopathology Core Facility VacV000 Pembrolizumab Oestrogen receptor-positive (ER+) breast cancer (BC)chemotherapy-ICI combinations breast cancer nivolumab

…n oncolytic Lister strain Vaccinia virus (VacV000; developed at QMUL and VacVBTX) in preclinical models of ER+ BC.Methods Human and …

936 Tumor-specific antibodies elicited by engineered bacteria promote bladder cancer immunotherapy

jitc · abstract · 2025-11-04 · 3 matching annotations

93.7%

Columbia University Irving Medical Center Jackson Laboratory Mendelsohn lab cancer cancerAbstract NIH/NCI R01CA249160 Charles H. Revson Foundation NIH/NCI R01CA259634 PD-1 blockade NIH/NCI U01CA247573+1 more

…g Comprehensive Cancer Center, and the Histology Service at the Columbia University Irving Medical Center. This work was supported by NIH/NCI R01CA249160, NIH/NCI R01CA2…

99 Research use only validation of ‘Off the Shelf’ multiPlex immunofluorescence panels with quantitative image analysis for use in retrospective clinical trials

jitc · abstract · 2025-11-04 · 3 matching annotations

80.1%

EC Institutional Review Board immunotherapy tyramide

…andard if outside the United States. Waiver of Consent: The IRB/EC has approved the use of Biospecimens and/or data without writte…